Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EVGN | US
-0.41
-16.08%
Healthcare
Biotechnology
30/06/2024
17/10/2024
2.14
2.54
2.54
2.14
Evogene Ltd. together with its subsidiaries operates as a computational biology company. It focuses on product discovery and development in life-science based industries including human health and agriculture through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture Human Health and Industrial Applications. The Agriculture segment develops seed traits ag-chemical products and ag-biological products to enhance plant performance. Its products focus on various crops such as corn soybean wheat rice and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology GI related disorders and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States Israel Brazil and internationally. The company has strategic collaborations and licensing agreements with agricultural companies such as BASF SE Corteva and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot Israel.
View LessLow Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
90.3%1 month
102.0%3 months
95.4%6 months
79.5%-
-
4.50
0.26
0.02
-0.81
0.39
-
-19.67M
11.15M
11.15M
-
-667.07
-
39.80
-82.37
0.63
0.27
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.93
Range1M
1.18
Range3M
5.18
Rel. volume
3.91
Price X volume
270.79K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
KTRA | KTRA | Biotechnology | 0.2154 | 11.99M | -6.31% | n/a | 0.00% |
DOMH | DOMH | Biotechnology | 1.88 | 11.80M | -3.09% | n/a | 7.66% |
BioRestorative Therapies Inc | BRTX | Biotechnology | 1.6815 | 11.64M | -2.80% | n/a | 0.77% |
Jaguar Health Inc | JAGX | Biotechnology | 1.23 | 11.37M | 0.00% | 0.26 | 176.14% |
Common Stock | ADXN | Biotechnology | 10.6 | 11.33M | 0.47% | n/a | 0.25% |
Immuron Limited | IMRN | Biotechnology | 1.97 | 11.22M | -1.99% | n/a | 1.37% |
TransCode Therapeutics Inc. Common Stock | RNAZ | Biotechnology | 0.599 | 10.78M | -11.79% | 0.00 | 17.19% |
Sensei Biotherapeutics Inc | SNSE | Biotechnology | 0.4237 | 10.66M | -7.69% | n/a | 9.67% |
RedHill Biopharma Ltd | RDHL | Biotechnology | 8.205 | 10.51M | -3.36% | n/a | 65.80% |
Alterity Therapeutics Limited | ATHE | Biotechnology | 1.2 | 10.49M | -4.00% | n/a | 1.15% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.81 | 0.53 | Cheaper |
Ent. to Revenue | 0.39 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 4.50 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 95.38 | 72.92 | Riskier |
Debt to Equity | 0.26 | -1.24 | Expensive |
Debt to Assets | 0.02 | 0.25 | Cheaper |
Market Cap | 11.15M | 3.78B | Emerging |